Skip to main content

Can you drink alcohol and take Repatha?

Medically reviewed by Melisa Puckey, BPharm. Last updated on Sep 19, 2023.

Official answer

by Drugs.com

Can I drink alcohol with Repatha injections?

There is not an interaction between drinking alcohol and having Repatha injections, so yes, you can drink alcohol with Repatha, but as always, drinking in moderation is best.

Binge drinking and Cholesterol levels.

  • Binge drinking of alcohol is known to cause an increase in lipid levels.
  • Repatha is a medicine that is used to reduce a patient's high cholesterol levels.
  • Therefore binge drinking should be avoided in patients with high cholesterol as it may increase the risk of the patient's cholesterol levels being increased.

Bottomline:

  • Alcohol can be consumed while on Repatha.
  • Drinking of alcohol should always be in moderation.
  • Binge drinking of alcohol can cause increases in cholesterol levels and increase risk of liver damage.
References

Read next

Are there any dangers of taking Repatha?

A serious danger of taking Repatha (evolocumab) includes a possibly life-threatening allergic reaction. Also tell your doctor if you are allergic to rubber or latex. Other side effects, which could be serious in some people, include high blood sugar levels (diabetes), respiratory tract infections, urinary tract infections (UTI), high blood pressure, and influenza (flu). Continue reading

Praluent vs Repatha: What's the difference?

The differences between Repatha (evolocumab) and Praluent (alirocumab) are their active ingredients, number of treatment indications, dosage forms available and number of strengths available in syringe and pens forms. Continue reading

What is the difference between Leqvio and Repatha?

Leqvio and Repatha are both injectable medicines that are used for the treatment of high cholesterol, by specifically lowering low density lipoprotein (LDL) levels. Although they both inhibit PCSK9 they work by different mechanisms. Repatha is a monoclonal antibody that binds directly to PCSK9 in the liver preventing it from binding to LDL receptors. Leqvio blocks the PCSK9 protein by interfering with the translation of PCSK9 messenger RNA. Both have the same result – and that is freeing up LDL receptors on the surface of liver cells which allows LDL cholesterol to be removed from the blood. Continue reading

Related medical questions

Drug information

Related support groups